Return On Equity of Dyne Therapeutics, Inc. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Dyne Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • Dyne Therapeutics, Inc. Return On Equity for the quarter ending 31 Dec 2025 was -61%, a 25% decline year-over-year.
  • Dyne Therapeutics, Inc. annual Return On Equity for 2025 was -61%, a 25% decline from 2024.
  • Dyne Therapeutics, Inc. annual Return On Equity for 2024 was -49%, a 64% increase from 2023.
  • Dyne Therapeutics, Inc. annual Return On Equity for 2023 was -136%, a 128% decline from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Dyne Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2025 -61% -12% -25% 01 Oct 2025 31 Dec 2025
Q3 2025 -66% -8.7% -15% 01 Jul 2025 30 Sep 2025
Q2 2025 -64% +4.7% +6.9% 01 Apr 2025 30 Jun 2025
Q1 2025 -53% +58% +52% 01 Jan 2025 31 Mar 2025
Q4 2024 -49% +87% +64% 01 Oct 2024 31 Dec 2024
Q3 2024 -57% +40% +41% 01 Jul 2024 30 Sep 2024
Q2 2024 -69% +11% +14% 01 Apr 2024 30 Jun 2024
Q1 2024 -111% -42% -62% 01 Jan 2024 31 Mar 2024
Q4 2023 -136% -77% -128% 01 Oct 2023 31 Dec 2023
Q3 2023 -98% -39% -67% 01 Jul 2023 30 Sep 2023
Q2 2023 -80% -28% -54% 01 Apr 2023 30 Jun 2023
Q1 2023 -69% -28% -68% 01 Jan 2023 31 Mar 2023
Q4 2022 -60% -25% -71% 01 Oct 2022 31 Dec 2022
Q3 2022 -58% -28% -95% 01 Jul 2022 30 Sep 2022
Q2 2022 -52% -28% -118% 01 Apr 2022 30 Jun 2022
Q1 2022 -41% -15% -58% 01 Jan 2022 31 Mar 2022
Q4 2021 -35% -1.7% -5.1% 01 Oct 2021 31 Dec 2021
Q3 2021 -30% +7.4% +20% 01 Jul 2021 30 Sep 2021
Q2 2021 -24% +251% +91% 01 Apr 2021 30 Jun 2021
Q1 2021 -26% +223% +90% 01 Jan 2021 31 Mar 2021
Q4 2020 -33% +296% +90% 01 Oct 2020 31 Dec 2020
Q3 2020 -37% 01 Jul 2020 30 Sep 2020
Q2 2020 -275% 01 Apr 2020 30 Jun 2020
Q1 2020 -249% 01 Jan 2020 31 Mar 2020
Q4 2019 -329% 01 Oct 2019 31 Dec 2019

Dyne Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2025 -61% -12% -25% 01 Jan 2025 31 Dec 2025
2024 -49% +87% +64% 01 Jan 2024 31 Dec 2024
2023 -136% -77% -128% 01 Jan 2023 31 Dec 2023
2022 -60% -25% -71% 01 Jan 2022 31 Dec 2022
2021 -35% -1.7% -5.1% 01 Jan 2021 31 Dec 2021
2020 -33% +296% +90% 01 Jan 2020 31 Dec 2020
2019 -329% 01 Jan 2019 31 Dec 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.